Supernus Pharmaceuticals, Inc. (SUPN) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to Sopernos Pharmaceuticals' first quarter 2025 financial results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. Instructions will follow at that time. As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vazzo of ICR Westwick, Investor Relations Representative for Sopernos Pharmaceuticals. You may begin. Thank you, Lauren. Good afternoon, everyone. Thank you for joining us today for Sopranos Bar & Suitable's first quarter 2025 financial results conference call. Today, after the close of the market, the company issued a press release announcing these results. On the call with me today are Sopranos Chief Executive Officer Jack Katar and Chief Financial Officer Tim Desch. This call is being made available via the investor relations section of the company's website at ir.sopranos.com. During the course of this call, management may make certain forward-looking statements regarding future events and the company's future performance. These forward-looking statements reflect Sopernos' current perspective on existing trends and information. Any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including those notes in the risk factor section of the company's latest S&P file. Actual results may differ materially and may be subjective in these forward-looking statements. For the benefit of those of you who may be listening to the replay, this call is being held and recorded on May 6th, 2025. Since then, the company may have made additional announcements related to the topics discussed. Please reference the company's most recent press releases and current f...